DNLI
Denali Therapeutics Inc
NASDAQ: DNLI · HEALTHCARE · BIOTECHNOLOGY
$18.60
-7.28% today
Updated 2026-04-29
Market cap
$2.95B
P/E ratio
—
P/S ratio
3,643.65x
EPS (TTM)
$-2.97
Dividend yield
—
52W range
$13 – $24
Volume
1.7M
Denali Therapeutics Inc (DNLI) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
—
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|